Premium Quality Pharmaceutical Cannabis Products
We cultivate and process pharmaceutical-grade cannabis into medicinal products that improve health and provide relief.
We Offer Full-Service
Cannabis and Hemp Testing
State-of-the-Art
Facility and Labs
Our facilities and laboratories are fully equipped with the latest technology and equipment for the indoor cultivation of cannabis.
Cultivation Area
Production Area
Growing Rooms
Class D Clean Rooms
Physico-chemical Laboratory
Microbiological Laboratory
Affordable Medicine for All
Our goal is to help develop medicinal products that will improve patient health and provide relief. Through ongoing scientific research and development, we aim to unlock the full therapeutic potential of cannabis, opening the doors to new and revolutionary medical treatments.
Latest News From Our Blog
Visit our blog to learn more about the latest activities, collaborations and achievements within our organization, and about the developments in the pharmaceutical cannabis industry.
Sinceritas AD Obtains Rigorous EU GMP Certification
Sinceritas AD Skopje obtains rigorous EU GMP Certification issued by a competent authority in Germany confirming the …
2022 • Year in Review
End-of-year is always an exciting period for us to take a moment, look back, and pay a tribute to what made the …
Purity and Quality
Above All
Let's Grow Together
Sinceritas houses a diverse team of talented people looking for continual improvement and growth.
This means that we are often looking for talented, determined and people who excel in their field with an ambition to join us full-time or for an internship.
Let's Grow Together
We are a diverse team of talented people that are looking to grow and continually improve.
This means that we are often looking for talented, determined people who excel in their field and would like to join us full-time or for an internship.
A New Standard in Medical Cannabis Testing and Manufacturing
Our facility complies with EU GMP and the International Organisation for Standardization (ISO 17025)
